156 related articles for article (PubMed ID: 11781283)
1. Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis.
Suleiman S; Rex DK; Sonnenberg A
Gastroenterology; 2002 Jan; 122(1):78-84. PubMed ID: 11781283
[TBL] [Abstract][Full Text] [Related]
2. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses.
Pence BC; Belasco EJ; Lyford CP
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):399-405. PubMed ID: 23250933
[TBL] [Abstract][Full Text] [Related]
3. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
DuPont AW; Arguedas MR; Wilcox CM
Aliment Pharmacol Ther; 2007 Aug; 26(3):431-41. PubMed ID: 17635378
[TBL] [Abstract][Full Text] [Related]
4. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
Ladabaum U; Chopra CL; Huang G; Scheiman JM; Chernew ME; Fendrick AM
Ann Intern Med; 2001 Nov; 135(9):769-81. PubMed ID: 11694102
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.
Hur C; Simon LS; Gazelle GS
Cancer; 2004 Jul; 101(1):189-97. PubMed ID: 15222006
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
9. Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis.
Ladabaum U; Scheiman JM; Fendrick AM
Am J Med; 2003 May; 114(7):546-54. PubMed ID: 12753878
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
11. Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759636
[No Abstract] [Full Text] [Related]
12. The cost-effectiveness of aspirin for chemoprevention of colorectal cancer.
Provenzale D
Gastroenterology; 2002 Jan; 122(1):230-3. PubMed ID: 11781299
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F
Arch Intern Med; 2002 Jan; 162(2):163-8. PubMed ID: 11802749
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors.
Gini A; Meester RGS; Keshavarz H; Oeffinger KC; Ahmed S; Hodgson DC; Lansdorp-Vogelaar I
J Natl Cancer Inst; 2019 Nov; 111(11):1161-1169. PubMed ID: 30980665
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness and projected national impact of colorectal cancer screening in France.
Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation.
Negrón ME; Kaplan GG; Barkema HW; Eksteen B; Clement F; Manns BJ; Coward S; Panaccione R; Ghosh S; Heitman SJ
Inflamm Bowel Dis; 2014 Nov; 20(11):2046-55. PubMed ID: 25230162
[TBL] [Abstract][Full Text] [Related]
17. Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis.
Arguedas MR; Heudebert GR; Wilcox CM
Aliment Pharmacol Ther; 2001 May; 15(5):631-8. PubMed ID: 11328256
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients.
Soon SS; Chia WK; Chan ML; Ho GF; Jian X; Deng YH; Tan CS; Sharma A; Segelov E; Mehta S; Ali R; Toh HC; Wee HL
PLoS One; 2014; 9(9):e107866. PubMed ID: 25250815
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
Wong CK; Lam CL; Wan YF; Fong DY
BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of screening the average-risk population for colorectal cancer.
Provenzale D
Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):93-109. PubMed ID: 11916165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]